Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Active Biotech in its new issue
Mandate

Vinge advises Active Biotech in its new issue

April 06, 2009

Vinge has advised Active Biotech in its new issue of shares subject to pre-emption rights for the existing shareholders. Under the new issue, which is underwritten in its entirety by the principal shareholders MGA Holding and Nordstjernan, Active Biotech receives approximately SEK 256 million.

Vinge’s team was led by Erik Sjöman who was assisted by, among others, associates Christian Lindhé, Karolina Tjärnberg Jansson and Maria Doeser (tax law advice).

Related

Vinge advises Fidelio Capital and Heart BidCo AB in connection with bond issue

 Vinge advises Fidelio Capital and Heart BidCo AB in connection with the SEK 900,000,000 senior secured bond issuance by Heart BidCo AB, the parent company in a group consisting of Hemfrid, Servly and other leading actors within the Swedish home services sector. Pareto Securities AB acted as sole bookrunner and issuing agent in connection with the transaction.
May 09, 2024

Vinge advises Rite Ventures on its mandatory bid for Nelly

Rite Internet Ventures Holding AB has, through its wholly-owned subsidiary Rite Ventures SPV AB, made a public mandatory offer for all shares in Nelly Group AB (publ). The offer values all shares in Nelly at approximately SEK 500 million. Vinge advises Rite Ventures.
May 08, 2024

Vinge advises PropTech Energy in connection with its acquisition of P2 Energi AB

 PropTech Energy consists of the companies Ömangruppen and Axcell Fastighetspartner. Through the acquisition of P2 Energi AB, an energy consulting company within heating, ventilation and cooling technology, PropTech Energy strengthens its focus on energy efficiency.
May 06, 2024